These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18688655

  • 1. A single-center study of C1q nephropathy in children.
    Roberti I, Baqi N, Vyas S, Kim DU.
    Pediatr Nephrol; 2009 Jan; 24(1):77-82. PubMed ID: 18688655
    [Abstract] [Full Text] [Related]

  • 2. Steroid-responsive nephrotic syndrome in a child with juvenile idiopathic arthritis.
    Bandin F, Merhenberger M, Modesto A, Brochard K, Decramer S.
    Pediatr Nephrol; 2008 Apr; 23(4):651-4. PubMed ID: 18038156
    [Abstract] [Full Text] [Related]

  • 3. C1q nephropathy and minimal change nephrotic syndrome.
    Wong CS, Fink CA, Baechle J, Harris AA, Staples AO, Brandt JR.
    Pediatr Nephrol; 2009 Apr; 24(4):761-7. PubMed ID: 19082635
    [Abstract] [Full Text] [Related]

  • 4. C1q nephropathy among children with nephrotic syndrome: Ten-year experience from a pediatric nephrology unit.
    Abu-Shahin N, Al-Khader A, Qattan D, Akl K.
    Turk J Pediatr; 2018 Apr; 60(1):14-21. PubMed ID: 30102475
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic correlation and outcome of C1q nephropathy.
    Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, Saitoh T, Takeshita M, Iwasaki H.
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1637-43. PubMed ID: 18650410
    [Abstract] [Full Text] [Related]

  • 6. C1Q nephropathy in children.
    Kersnik Levart T, Kenda RB, Avgustin Cavić M, Ferluga D, Hvala A, Vizjak A.
    Pediatr Nephrol; 2005 Dec; 20(12):1756-61. PubMed ID: 16247648
    [Abstract] [Full Text] [Related]

  • 7. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Wong SC, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
    [Abstract] [Full Text] [Related]

  • 9. A clinicopathological study of C1q nephropathy at King Abdulaziz University.
    Mokhtar GA, Jalalah SM.
    Iran J Kidney Dis; 2015 Jul 11; 9(4):279-85. PubMed ID: 26174454
    [Abstract] [Full Text] [Related]

  • 10. Pathology, clinical presentations, and outcomes of C1q nephropathy.
    Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcić V, Jennette JC.
    J Am Soc Nephrol; 2008 Nov 11; 19(11):2237-44. PubMed ID: 18650484
    [Abstract] [Full Text] [Related]

  • 11. Change in C1q deposition in C1q nephropathy.
    Kaneko K, Hasui M, Hatae K, So H, Katafuchi R.
    Pediatr Nephrol; 2009 Sep 11; 24(9):1775. PubMed ID: 19288139
    [No Abstract] [Full Text] [Related]

  • 12. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K, Ito H, Anzai M, Matsumura C, Kurayama H.
    J Nephrol; 2013 Sep 11; 26(2):306-14. PubMed ID: 22641570
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 11; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.
    Roberti I, Vyas S.
    Pediatr Nephrol; 2010 Jun 11; 25(6):1117-24. PubMed ID: 20217433
    [Abstract] [Full Text] [Related]

  • 15. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY.
    Histopathology; 1984 May 11; 8(3):435-46. PubMed ID: 6376323
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 11; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 17. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 11; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 18. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
    Tune BM, Mendoza SA.
    J Am Soc Nephrol; 1997 May 11; 8(5):824-32. PubMed ID: 9176855
    [Abstract] [Full Text] [Related]

  • 19. C1q nephropathy in a 2-year-old boy presenting with steroid resistant nephrotic syndrome.
    Niimura F, Kamei A, Tamame T, Yamada K, Komaki F, Okamoto S, Matsuda S, Oh Y, Endoh M.
    Tokai J Exp Clin Med; 2007 Sep 20; 32(3):95-8. PubMed ID: 21318945
    [Abstract] [Full Text] [Related]

  • 20. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 20; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.